Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Amortizatization of Intangibles (2019 - 2025)

Syndax Pharmaceuticals (SNDX) has 7 years of Amortizatization of Intangibles data on record, last reported at $1.5 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 47.96% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $10.8 million, down 20.16%, while the annual FY2025 figure was $10.8 million, 20.16% down from the prior year.
  • Amortizatization of Intangibles reached $1.5 million in Q4 2025 per SNDX's latest filing, down from $2.4 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.0 million in Q1 2023 and bottomed at -$187000.0 in Q2 2021.
  • Average Amortizatization of Intangibles over 5 years is $2.1 million, with a median of $2.7 million recorded in 2024.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 8750.0% in 2021, then surged 7384.91% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$171000.0 in 2021, then surged by 1284.21% to $2.0 million in 2022, then surged by 70.81% to $3.5 million in 2023, then dropped by 15.0% to $2.9 million in 2024, then tumbled by 47.96% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $1.5 million in Q4 2025, $2.4 million in Q3 2025, and $3.2 million in Q2 2025.